Seagen Seagen (formerly known as Seattle Genetics) is a biotechnology company that develops and commercializes targeted therapies to treat cancer. | Immunomedics Immunomedics is a developer of monoclonal antibody-based products for the targeted treatment of cancer. | PIN Pharma PIN Pharma is a biopharmaceutical company focused on developing broad-base immuno-modulatory therapies, linking the innate and adaptive immune systems. | |
Founding Date | Founding Date 1998 | Founding Date 1982 | Founding Date 2011 |
Type | Type Subsidiary | Type Subsidiary | Type Private |
Tags | |||
Locations | Locations Bothell, US HQ Mississauga, CA Hørsholm, DK Rueil Malmaison, FR München, DE Milano, IT Schiphol, NL see more | Locations Morris Plains, US HQ | Locations New York, US HQ |
Employees | Employees 3,25622% increase | Employees 102 | Employees 1 |
Financial | |||
Revenue (est.) | Revenue (est.) $2b (FY, 2022) | Revenue (est.) $295k (FY, 2019) | Revenue (est.) N/A |
Cost of goods | Cost of goods $410.1m (FY, 2022) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit $1.6b (FY, 2022) | Gross profit $295k (FY, 2019) | Gross profit N/A |
Net income | Net income ($610.3m) (FY, 2022) | Net income ($357.3m) (FY, 2019) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 164m | Total funding raised $ 30m | Total funding raised N/A |